Pfizer Releases New Data From Maternal RSV Vaccine Trials

Pfizer Releases New Data From Maternal RSV Vaccine Trials


Pfizer has released new data from its trials for a potential maternal vaccine against the common respiratory virus RSV that shows an 81 percent effectiveness against severe illness in the first 90 days of a newborn’s life. NBC News medical contributor Dr. Kavita Patel has the details. 

» Subscribe to NBC News: http://nbcnews.to/SubscribeToNBC
» Watch more NBC video: http://bit.ly/MoreNBCNews

NBC News Digital is a collection of innovative and powerful news brands that deliver compelling, diverse and engaging news stories. NBC News Digital features NBCNews.com, MSNBC.com, TODAY.com, Nightly News, Meet the Press, Dateline, and the existing apps and digital extensions of these respective properties. We deliver the best in breaking news, live video coverage, original journalism and segments from your favorite NBC News Shows.

Connect with NBC News Online!
NBC News App: https://smart.link/5d0cd9df61b80
Breaking News Alerts: https://link.nbcnews.com/join/5cj/breaking-news-signup?cid=sm_npd_nn_yt_bn-clip_190621
Visit NBCNews.Com: http://nbcnews.to/ReadNBC
Find NBC News on Facebook: http://nbcnews.to/LikeNBC
Follow NBC News on Twitter: http://nbcnews.to/FollowNBC

#Pfizer #Covid19 #RSV

You May Also Like

Leave a Reply

Your email address will not be published. Required fields are marked *